Eyk Henning

Brummt das Geschäft, läuft es auch mit der Beförderung. Der Wall-Street-Titan Goldman Sachs hat erstmals seit mindestens einem Jahrzehnt gleich zwei Deutsche in die Riege seiner Partner aufgenommen.

Stada Arzneimittel AG’s private equity owners have selected bookrunners for a potential initial public offering of the consumer health-focused drugmaker with plans to launch the deal early next year, according to people familiar with the matter.

Triton Partners is considering a takeover bid for Germany’s Evotec SE, according to people familiar with the matter, after the private equity firm emerged as one of the drug developer’s largest shareholders.

Triton erwägt dem Vernehmen nach ein Übernahmegebot für die Hamburger Evotec. In der vergangenen Woche hatte der Finanzinvestor seine Beteiligung laut Stimmrechtsmitteilungen durch eine Reihe von Transaktionen auf 9,99% aufgestockt und wurde damit zu einem der größten Anteilseigner.

Nabeel Bhanji, a London-based partner at Elliott Investment Management who worked on some of the activist investment firm’s most high-profile campaigns, is leaving after more than a decade.

Baloise Holding AG has become one of the most-discussed takeover candidates in the European financial sector, after agitation by an activist investor

(Bloomberg) -- Triton Partners is considering a takeover bid for Germany’s Evotec SE, according to people familiar with the matter, after the private equity firm emerged as one of the drug developer’s largest shareholders. Most Read from BloombergThe Leaf Blowers Will Not Go QuietlyArizona Elections Signal Robust Immigration Enforcement Under TrumpScoring an Architectural Breakthrough in Denver’s RiNo DistrictKey Ballot Initiatives and Local Races Highlight Views on Abortion, ImmigrationTriton i

Eyk Henning 2 min read In This Article (Bloomberg) -- Germany's Evotec SE is attracting potential takeover interest from

(Bloomberg) -- Germany’s Evotec SE is attracting potential takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc., people familiar with the matter said. Most Read from BloombergUnder Trump, Prepare for New US Transportation PrioritiesZimbabwe City of 700,000 at Risk of Running Dry by Year-EndSaudi Neom Gets $3 Billion Loan Guarantee From Italy Export Credit Agency SaceNYC Congestion Pricing Plan With $9 Toll to Start in JanuaryThe Urban-Rural Divide Over Highway Expansion a

(Bloomberg) -- Evotec SE has attracted takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc. for a deal that would value the German drug developer at €2 billion ($2.1 billion). Most Read from BloombergUnder Trump, Prepare for New US Transportation PrioritiesZimbabwe City of 700,000 at Risk of Running Dry by Year-EndSaudi Neom Gets $3 Billion Loan Guarantee From Italy Export Credit Agency SaceThe Urban-Rural Divide Over Highway Expansion and EmissionsHalozyme said in a stat